Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation

Platelets

Volumn 22, Issue 3, 2011, Pages 217-227

  Schinner, Elisabeth ^a   Salb, Katharina ^a   Schlossmann, Jens ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

granule secretion; IRAG; Nitric oxide NO; platelet adhesion; signal transduction

Indexed keywords

ADENOSINE TRIPHOSPHATE; COLLAGEN; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE TYPE I; FIBRINOGEN; FIBRINOGEN RECEPTOR; INOSITOL TRISPHOSPHATE; INOSITOL TRISPHOSPHATE RECEPTOR ASSOCIATED CGMP KINASE SUBSTRATE; NITRIC OXIDE; PADGEM PROTEIN; SEROTONIN; THROMBIN; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; CELL GRANULE; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE DISORDER; WILD TYPE;

ANIMALS; BLOOD PLATELETS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATORS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NITRIC OXIDE; PHOSPHOPROTEINS; PLATELET ACTIVATION; SIGNAL TRANSDUCTION;

MURINAE; MUS;

EID: 79954563422     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.544151     Document Type: Article

References (38)

1. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Brit J Pharmacol 2006;147(Suppl 1):S193-201. (Pubitemid 43077277)
2. Walter U, Gambaryan S. Roles of cGMP/cGMP-dependent protein kinase in platelet activation. Blood 2004;104:2609. (Pubitemid 39331870)
3. Hofmann F. The biology of cyclic GMP-dependent protein kinases. J Biol Chem 2005;280:1-4. (Pubitemid 40164957)
4. Friebe A, Koesling D. The function of NO-sensitive guanylyl cyclase: What we can learn from genetic mouse models. Nitric Oxide 2009;21:149-56.
5. Garthwaite J. New insight into the functioning of nitric oxidereceptive guanylyl cyclase: Physiological and pharmacological implications. Mol Cell Biochem 2010;334:221-32.
6. Massberg S, Sausbier M, Klatt P, Bauer M, Pfeifer A, Siess W, et al. Increased adhesion and aggregation of platelets lacking cyclic guanosine 30,50-monophosphate kinase I. J Exp Med 1999;189:1255-1264.
7. Hofmann F, Feil R, Kleppisch T, Schlossmann J. Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 2006;86:1-23.
8. Dangel O, Mergia E, Karlisch K, Groneberg D, Koesling D, Friebe A. NO-sensitive guanylyl cyclase is the only NO receptor mediating platelet inhibition. J Thromb Haemost 2010;8:1343-1352.
9. Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001;62:1153-1161. (Pubitemid 33055619)
10. Walter U, Gambaryan S. cGMP and cGMP-dependent protein kinase in platelets and blood cells. Handbook Exp Pharmacol 2009;191:533-548.
11. Schlossmann J, Ammendola A, Ashman K, Zong X, Huber A, Neubauer G, et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 2000;404:197-201. (Pubitemid 30154489)
12. Cifuni SM, Wagner DD, Bergmeier W. CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood 2008;112:1696-1703.
13. Shirakawa R, Yoshioka A, Horiuchi H, Nishioka H, Tabuchi A, Kita T. Small GTPase Rab4 regulates Ca2+-induced alphagranule secretion in platelets. J Biol Chem 2000;275:33844-33849.
14. Tolmachova T, Abrink M, Futter CE, Authi KS, Seabra MC. Rab27b regulates number and secretion of platelet dense granules. Proc Nat Acad Sci USA 2007;104:5872-5877. (Pubitemid 47175626)
15. Desch M, Sigl K, Hieke B, Salb K, Kees F, Bernhard D, et al. IRAG determines nitric oxide- and atrial natriuretic peptide-mediated smooth muscle relaxation. Cardiovasc Res 2010;86:496-505.
16. Geiselhoringer A, Gaisa M, Hofmann F, Schlossmann J. Distribution of IRAG and cGKI-isoforms in murine tissues. FEBS Letters 2004;575:19-22. (Pubitemid 39237675)
17. Antl M, von Bruhl ML, Eiglsperger C, Werner M, Konrad I, Kocher T, et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 2007;109:552-559. (Pubitemid 46105953)
18. Bergmeier W, Schulte V, Brockhoff G, Bier U, Zirngibl H, Nieswandt B. Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody. Cytometry 2002;48:80-86. (Pubitemid 34591919)
19. Crittenden JR, Bergmeier W, Zhang Y, Piffath CL, Liang Y, Wagner DD, et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004;10:982-986. (Pubitemid 39273740)
20. Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994;216:444-50. (Pubitemid 24076032)
21. Fung CY, Brearley CA, Farndale RW, Mahaut-Smith MP. A major role for P2X1 receptors in the early collagen-evoked intracellular Ca2+ responses of human platelets. Thromb Haemostasis 2005;94:37-40. (Pubitemid 40974702)
22. Rendu F, Brohard-Bohn B. The platelet release reaction: Granules' constituents, secretion and functions. Platelets 2001;12:261-273. (Pubitemid 32730513)
23. Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: The molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemostasis 2001;86:214-221. (Pubitemid 32666187)
24. Kahner BN, Shankar H, Murugappan S, Prasad GL, Kunapuli SP. Nucleotide receptor signaling in platelets. J Thromb Haemost 2006;4:2317-2326. (Pubitemid 44575423)
25. Strehl A, Munnix IC, Kuijpers MJ, van der Meijden PE, Cosemans JM, Feijge MA, et al. Dual role of platelet protein kinase C in thrombus formation: Staimulation of proaggregatory and suppression of procoagulant activity in platelets. J Biol Chem 2007;282:7046-7055. (Pubitemid 47093677)
26. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006;99:1293-1304. (Pubitemid 44949665)
27. Bennett JS. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005;115:3363-3369. (Pubitemid 43121820)
28. Aszodi A, Pfeifer A, Ahmad M, Glauner M, Zhou XH, Ny L, et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonistinduced platelet aggregation, but is dispensable for smooth muscle function. EMBO J 1999;18:37-48. (Pubitemid 29005021)
29. Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V, Geiger J, et al. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilatorstimulated phosphoprotein knockout mice. Proc Nat Acad Sci USA 1999;96:8120-8125. (Pubitemid 29328418)
30. Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010;42:608-613.
31. Rajendran S, Chirkov YY. Platelet hyperaggregability: Impaired responsiveness to nitric oxide (''platelet NO resistance'') as a therapeutic target. Cardiovascular Drugs and Therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy 2008;22:193-203.
32. Ozuyaman B, Godecke A, Kusters S, Kirchhoff E, Scharf RE, Schrader J. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation. Thrombosis Haemostasis 2005;93:1161-1167. (Pubitemid 40823523)
33. Reid HM, Kinsella BT. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for nitric oxide-mediated desensitization. Independent modulation of Tp alpha signaling by nitric oxide and prostacyclin. J Biol Chem 2003;278:51190-51202. (Pubitemid 38020356)
34. Wang GR, Zhu Y, Halushka PV, Lincoln TM, Mendelsohn ME. Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMPdependent protein kinase. Proc Nat Acad Sci USA 1998;95:4888-4893. (Pubitemid 28208520)
35. Slotta JE, Braun OO, Menger MD, Thorlacius H. Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162. Platelets 2009;20: 505-512.
36. Fung CY, Cendana C, Farndale RW, Mahaut-Smith MP. Primary and secondary agonists can use P2X(1) receptors as a major pathway to increase intracellular Ca(2+) in the human platelet. J Thromb Haemost 2007;5:910-917. (Pubitemid 46691718)
37. Galan AM, Lopez-Vilchez I, Diaz-Ricart M, Navalon F, Gomez E, Gasto C, et al. Serotonergic mechanisms enhance platelet-mediated thrombogenicity. Thrombosis Haemostasis 2009;102:511-519.
38. Hoffmeister M, Riha P, Neumuller O, Danielewski O, Schultess J, Smolenski AP. Cyclic nucleotide-dependent protein kinases inhibit binding of 14-3-3 to the GTPase-activating protein Rap1GAP2 in platelets. J Biol Chem 2008;283: 2297-2306.